Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exact Sciences Corp (NASDAQ:EXAS)

6.50
Delayed Data
As of May 27
 +0.55 / +9.24%
Today’s Change
4.67
Today|||52-Week Range
32.85
-29.58%
Year-to-Date
Billionaire Battleground: Exact Sciences Inc.
May 28 / MotleyFool.com - Paid Partner Content
Bull Vs. Bear: Exact Sciences Corporation
May 20 / MotleyFool.com - Paid Partner Content
Why Exact Sciences Stock Soared 10% Today
May 24 / MotleyFool.com - Paid Partner Content
Better Buy: Myriad Genetics, Inc. vs. Exact Sciences
May 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close5.95
Today’s open5.95
Day’s range5.81 - 6.50
Volume1,702,202
Average volume (3 months)1,973,914
Market cap$635.6M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-36.80%
Earnings growth (this year)-17.23%
Earnings growth (next 5 years)+22.50%
Revenue growth (last year)+2,093.38%
P/E ratioNM
Price/Sales21.56
Price/Book1.92

Competitors

 Today’s
change
Today’s
% change
LDRHLDR Holding Corp+0.21+1.01%
ANIKAnika Therapeutics I...+0.85+1.83%
CERSCerus Corp-0.04-0.72%
CSIICardiovascular Syste...+0.60+3.63%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$39.4M
Annual profit (last year)-$157.8M
Net profit margin-400.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kevin T. Conroy
Chief Operating Officer, Director &
Senior VP
Maneesh K. Arora
Corporate headquarters
Madison, Wisconsin

Forecasts

Partner Offers

Search for Jobs